ロード中...

ROADMAP and ORIENTAL Trials: the Re-emergence of J-Curve Ghost?

It still remains unknown whether angiotensin-receptor blockers (ARBs) are cardioprotective in patients with type 2 diabetes. The recent two clinical trials, the ROADMAP and the ORIENT, have suggested that fatal cardiovascular events or cardiovascular deaths were unexpectedly higher in olmesartan gro...

詳細記述

保存先:
書誌詳細
主要な著者: Hamamoto, Yoshiyuki, Koshiyama, Hiroyuki
フォーマット: Artigo
言語:Inglês
出版事項: Libertas Academica 2011
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3699452/
https://ncbi.nlm.nih.gov/pubmed/23885187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/JCM.S7521
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!